LAURA DAMME

Insider Reports History

Location
Andover, MA
Signature
By: /s/ Stephen Gordon, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by LAURA DAMME:

Company Role Class Num Shares Value Price $ Report Date Ownership
TransMedics Group, Inc. VP, Clinical Affairs Common Stock 5,685 $512,162 $90.09 20 Feb 2023 Direct
TransMedics Group, Inc. VP, Clinical Affairs Stock Option (Right to Buy) 8,705 20 Feb 2023 Direct

Insider Reports Filed by LAURA DAMME

Symbol Company Period Transactions Value $ Form Type Role Filing Time
TMDX TransMedics Group, Inc. 20 Feb 2023 2 $0 4 VP, Clinical Affairs 22 Feb 2023, 19:00
TMDX TransMedics Group, Inc. 14 Dec 2022 9 -$245,110 4 VP, Clinical Affairs 16 Dec 2022, 15:30
TMDX TransMedics Group, Inc. 22 Feb 2022 1 $0 4 VP, Clinical Affairs 24 Feb 2022, 16:48